Over 2 years ago this stock was trading at $20, now it’s leveled off around $2. One insider just spent $1.7 MILLION of his own money on shares, and more are following, after an application was submitted to the FDA for a proprietary genetic treatment targeting a market estimated as worth over $10 billion. To get access to this weeks special report and daily market bulletin, please enter your name and email address below. This special report is a live sample of our Tech Stock product, so if you have any questions, call us or email us though our contact page. We dislike ‘spam’ as much as you, so you have our guarantee that your email address will NEVER be sold to any third party, and your peace and privacy will be respected.
